Business
MDCorp Signs LOI For Acquisition, European Medical Distribution Business
MDCorp Signs LOI For Acquisition, European Medical Distribution Business.
About this update from Qian Yuan Baixing, Inc.
[{"type":"text","content":"\n\n\n\nMDCorp Signs LOI For Acquisition, European Medical Distribution Business\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nMDCorp Signs LOI For Acquisition, European Medical Distribution Business\nPR Newswire\nSEATTLE, June 2, 2017\n\n\n\n\n\n\n\nSEATTLE, June 2, 2017 /PRNewswire/ -- MDCorp (OTC: MDCX) has executed an LOI to acquire 100% equity stake in Terramed, Ltd., Intellemed Ltd., Neuraxon, Ltd. hereafter described as \"European Distribution Medical Systems\" (EDMS).   The EDMS group shall upon successful acquisition, if completed, become a wholly owned subsidiary of MDCorp. \n\nEDMS represents a trio of European Medical distribution companies headed by Mr. Pantelis Stanitsas historically covering 6 countries in the European Union with sales channels into the United Kingdom, Greece, Cyprus, Romania, Bulgaria, and Kazakhstan.  Revenues currently in the neighborhood of $5 million Euros are expected to expand with additional CAPEX funding.  It is expected that our cooperation and acquisition shall allow EDMS as a wholly owned subsidiary of MDCorp to take advantage of new products and services layered across an existing, growing base of new branch offices.\n\nEDMS seeks to utilize over 15 years of local market expertise and funding from MDCorp to open new branch offices and expand sales, layering more products and services through existing and then new sales channels.\n\nInquiries:  [email protected]\n\nForward-Looking Statements\n\nThis press release contains \"forward-looking statements\" within the meaning of the \"safe harbor\" provisions of the Private Securities Litigation Reform Act of 1995, including but not limited to, statements regarding the MDCorp's position as a market leader, acceleration of innovation and expansion of total addressable market opportunity.  These forward-looking statements are made as of the date they were first issued and were based on current expectations, estimates, forecasts and projections as well as the beliefs and assumptions of management. Words such as \"expect,\" \"anticipate,\" \"s...